Introduction {#sec1-1}
============

Drug-induced Parkinsonism (DIP) is the second most prevalent cause of secondary Parkinsonism. Its symptoms, which include tremor, rigidity, bradykinesia, and gait disturbance, are very similar to those of Parkinson's disease (PD). Initially reported as a complication of antipsychotics, it was later recognized as a common complication of antidepressants, calcium channel antagonists, gastrointestinal prokinetics, antiepileptic drugs, and many other compounds. ^[@ref1],[@ref2]^ DIP is particularly burdensome for the elderly and its management includes the recognition of symptoms and identification of risk factors and offending agents. Prompt discontinuation of the causative agent often leads to marked improvement, though the condition might persist or remit slowly in up to 10% of patients. These patients are often suspected of concomitantly developing PD.^[@ref3]^ DIP shows more rapid progress, symmetry of symptoms, relative absence of rest tremor, and coexistence of oro-mandibular dyskinesias compared with PD. However, differentiating DIP from PD in such cases is difficult.^[@ref2],[@ref4]^

Additionally, DIP is frequently overlooked^[@ref5]^ and its clinical course is not well understood because the majority of cases are caused by drugs prescribed by departments outside of neurology. Therefore, we aimed to examine the clinical course of DIP.

Materials and Methods {#sec1-2}
=====================

We reviewed 21 cases of drug-induced Parkinsonism and gathered information on 13 different parameters to study the clinical course of the illness. These parameters included: age at onset, sex, whether the case was inpatient or outpatient, maximum Hoehn and Yahr Scale score, causative drug, reason for prescribing the drug, department by which the drug was prescribed, description of any involuntary movement, brain abnormalities (as determined by magnetic resonance imaging \[MRI\]), use of any anti-parkinsonism drugs, neuromuscular diseases before DIP onset, outcome, duration of causative drug use before DIP onset, time to recovery after withdrawal of causative drug and difficulties after drug withdrawal ([Table 1](#table001){ref-type="table"}).

Results {#sec1-3}
=======

The age at onset ranged from 40 to 87 years, with 90% of patients over the age of 65 years and a male: female ratio of 2:5. The average Hoehn and Yahr Scale score was 4, which was indicative of severe disability. Two patients showed oromandibular dyskinesia ([Table 1](#table001){ref-type="table"}). Sulpiride was the most common causative drug (71.4%); other drugs included tiapride, metoclopramide, maprotiline, haloperidol, and risperidone ([Figure 1](#fig001){ref-type="fig"}). All causative drugs were prescribed in departments that did not specialize in neurology, with a large portion prescribed by psychiatric departments (eight cases; 38.1%). In the remaining 13 cases (61.9%), drugs were prescribed in a nonpsychiatric department, which included seven by a general practitioner, three in a general hospital's surgical department, two in a general hospital's internal medicine department, and one in a nursing home ([Figure 2A](#fig002){ref-type="fig"}). Commonly cited reasons for prescription included depression (29%), other psychiatric symptoms (33%), abdominal discomfort (19%), and unknown (19%) ([Figure 2B](#fig002){ref-type="fig"}).

Based on clinical symptoms and neuroimaging (MRI and computed tomography) findings, neuromuscular diseases were not present in 11 of the cases (52%) before symptom onset. However, these diseases were present in the remaining 48%, which included cerebrovascular diseases (28%; five vascular dementia, one higher-order dysfunction due to multiple cerebral infarction, and one hemiplegia), three with neurodegenerative diseases (14.3%; Parkinson's disease, familial spastic paraplegia, and geriatric dementia), and one with depression (4.8%) ([Figure 3A](#fig003){ref-type="fig"}). After withdrawal of the causative medication, 15 of the patients (71%) were once again able to walk at home, but three were wheelchairbound and one died from malignant syndrome ([Figure 3B](#fig003){ref-type="fig"}).

In 13 patients from 15 patients who were again able to walk, we could examine the relationship between the length of time from first administration of the causative drug to the onset of symptoms and the length of time until recovery after drug withdrawal. It was found that the length of time from first administration of the drug until symptom onset ranged from 1 to 64 weeks (mean 23.2±42.7 weeks), while the period for recovery ranged from 1 to 16 weeks (average 13.2±4.7 weeks). There was no significant correlation between symptom onset and recovery ([Figure 4](#fig004){ref-type="fig"}).

Discussion {#sec1-4}
==========

Examination of 21 cases of druginduced Parkinsonism (DIP) from our department showed that DIP was more common in elderly women, which is consistent with the known risk factors for DIP.^[@ref3]^ Additionally, DIP progressed more rapidly than Parkinson's disease. Despite the patients having Hoehn and Yahr Scale ratings between 4 and 5, cessation of the medication resulted in relatively rapid recovery. The patients were able to fully recover and return to their baseline state; 15 of 21 cases (71.4%) had good outcomes in that they were able to walk at home after drug withdrawal. However, there were cases in which the patient entered a geriatric facility and became wheelchair-bound, as well as one case of death due to malignant syndrome.

These data suggest that prescription by departments outside of psychiatry accounts for more than 60% of DIP cases. It is possible that these medications are being prescribed by physicians with a minimal understanding of their dangerous side effects; therefore, more attention from the prescribing physician is required. Lopes-Sendon *et al*.^[@ref3]^ found that the risk factors for developing DIP included older age; female sex; cognitive impairment; potency, dose, and length of treatment; and pre-existing extrapyramidal signs. More attention should be paid to the risk factors of DIP.

We also found there to be some difficulties associated with drug withdrawal because some cases experienced side effects after withdrawal of the causative drug. For example, some patients experienced abdominal discomfort, psychiatric symptoms, insomnia, or behavioral and psychological symptoms of dementia following withdrawal. In these cases, the symptoms experienced following withdrawal were the main reasons for the prescription. If the medication cannot be withdrawn, the dose should be lowered or the medication switched to reduce the risk of DIP. Additionally, another problem experienced following withdrawal of the causative drug is oromandibular dyskinesia. Shin *et al.* found that levosulpiride-induced movement disorders are often severe, and are irreversible even after withdrawal of the drug.^[@ref8]^ In our study, there was a patient who still showed oromandibular dyskinesia after drug withdrawal. Physicians should be also cautious of such symptoms.

Conclusions {#sec1-5}
===========

In our study, all of the causative drugs were prescribed in non-neurological departments, and more than 60% were prescribed in non-psychiatric departments. Approximately 70% of patients recovered after drug withdrawal; however, the remaining patients did not. We suggest that neurologists pay closer attention to the Parkinsonian side effects of these commonly prescribed drugs.
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![Sulpiride was the most common causative drug (71.4%). The other causative drugs were tiapride, metoclopramide, maprotiline, haloperidol, and risperidone.](ni-10-4-7877-g001){#fig001}

![All causative drugs were prescribed in non-neurological departments. Drugs were prescribed in 8 cases (38.1%) in psychiatric and in 13 cases (61.9%) in non-psychiatric departments, which included prescriptions from seven general practitioners, three general hospital surgeons, two general hospital internal medicine physicians, and one nursing home physician. In total, over half of the causative drugs were prescribed in non-psychiatric departments (A). The main reasons for prescribing were listed as depression (29%), psychiatric symptoms (33%), abdominal discomfort (19%), and unknown (19%) (B).](ni-10-4-7877-g002){#fig002}

![Based on clinical symptoms and neuroimaging findings, 11 of the 21 cases (52%) had no presence of neuromuscular diseases before DIP onset. The remaining 48% did, which included cerebrovascular diseases (28%; five vascular dementia, one higher-order dysfunction due to multiple cerebral infarction, and one hemiplegia), neurodegenerative diseases (14.3%; one Parkinson's disease, one case of familial spastic paraplegia, and one case of geriatric dementia), and depression (4.8%) (A). Fifteen of the patients (71%) had a good outcome in that they were able to walk at home after withdrawal of the causative drug, but three were wheelchair-bound and one died from malignant syndrome (B).](ni-10-4-7877-g003){#fig003}

![There was no significant correlation between duration of use of the causative drug before DIP onset and time to recovery after drug withdrawal.](ni-10-4-7877-g004){#fig004}

###### 

Summary of the characteristics of the 21 patients with drug-induced Parkinsonism.

  Age at onset   Sex   Outpatient/ hospitalized   Maximum Hoehn-Yahl   Causative drug          Department by which the causative drug was prescribed   Reason for prescription          Involuntary movement       Brain MRI findings                                              Anti-Parkinsonism drug used                       Neuromuscular diseases before symptom onset   Outcome                                     Duration of causative drug use before DIP onset (weeks)   Time to recovery after withdrawal of causative drug   Problems after withdrawal of the causative drug
  -------------- ----- -------------------------- -------------------- ----------------------- ------------------------------------------------------- -------------------------------- -------------------------- --------------------------------------------------------------- ------------------------------------------------- --------------------------------------------- ------------------------------------------- --------------------------------------------------------- ----------------------------------------------------- -------------------------------------------------
  84             F     Outpatient                 V                    Causative drug          General practitioner                                    Depression                       Oromandibular dyskinesia   Lacunes in bilateral basal ganglia                              None                                              None                                          Independent on activities of daily living   12                                                        6                                                     Oromandibular dyskinesia
  80             F     Outpatient                 IV                   Sulpiride 150 mg/day    Nursing home                                            Abdominal discomfort             Rt. hand tremor            Lacunes in bilateral white matter                               None                                              None                                          Independent on activities of daily living   64                                                        8                                                     Abdominal discomfort
  68             F     Outpatient                 III                  Sulpiride 100 mg/day    Psychiatry                                              Depression                       None                       Lacune in left putamen                                          None                                              None                                          Independent on activities of daily living   40                                                        4                                                     None
  78             F     Outpatient                 V                    Tiapride 75 mg/day      General hospital surgery                                Hallucination                    Oromandibular dyskinesia   Widespread white matter hyperintensities                        L-DOPA 100 mg/day (discontinued)                  Vascular dementia                             Able to walk at home                        24                                                        16                                                    Dementia
  81             M     Outpatient                 IV                   Metoclopramide          General practitioner                                    Abdominal discomfort             Rt. hand tremor            Cortical infarct                                                L-DOPA 150 mg/day                                 None                                          Independent on activities of daily living   12                                                        8                                                     None
  71             F     Outpatient                 V                    Tiapride 75 mg/day      General practitioner                                    Malaise                          Limb and jaw tremor        Lacunes in bilateral white matter                               None                                              None                                          Independent on activities of daily living   12                                                        3                                                     Malaise
  83             F     Outpatient                 IV                   Sulpiride 150 mg/day    General practitioner                                    Unknown                          None                       Widespread white matter hyperintensities                        None                                              Vascular dementia                             Independent on activities of daily living   48                                                        4                                                     None
  74             F     Outpatient                 IV                   Sulpiride 150 mg/day    General practitioner                                    Anorexia, abdominal discomfort   Rt. hand, jaw tremor       Lacunes in bilateral white matter, basal ganglia and thalamus   None                                              None                                          Unknown                                     Unknown                                                   Unknown                                               Unknown
  66             F     Outpatient                 IV                   Sulpiride 200 mg/day    Psychiatry                                              Depression                       None                       Unknown                                                         None                                              None                                          Unknown                                     Unknown                                                   Unknown                                               Unknown
  66             M     Hospitalized               V                    Haloperidol 5 mg/day    General hospital surgery                                Insomnia                         None                       Normal                                                          L-DOPA 100 mg/day                                 Parkinson's disease                           Independent on activities of daily living   1                                                         1                                                     Parkinson's disease
  86             F     Hospitalized               V                    Sulpiride 100 mg/day    General practitioner                                    Hallucination                    None                       Widespread white matter                                         L-DOPA 100 mg/day                                 Vascular dementia                             Able to walk at home                        6                                                         8                                                     Dementia
  40             F     Hospitalized               V                    Sulpiride 300 mg/day    Psychiatry                                              Psychiatric symptoms             None                       Normal                                                          L-DOPA 200 mg/day (discontinued)                  Hereditary spasticparaparesis                 Independent on activities of daily living   10                                                        4                                                     Psychiatric symptoms
  83             F     Hospitalized               V                    Sulpiride 200 mg/day    General hospital internal medicine                      Irritation, insomnia             Lt. hand tremor            Widespread white matter hyperintensities                        None                                              None                                          Independent on activities of daily living   12                                                        16                                                    None
  86             M     Hospitalized               IV                   Sulpiride 100 mg/day    General hospital internal medicine                      Anorexia, abdominal discomfort   None                       Cortical infarcts                                               None                                              Multiple infarction                           Independent on activities of daily living   4                                                         4                                                     None
  59             F     Hospitalized               V                    Risperidone 9 mg/day    Psychiatry                                              Depression, delusion             Hand tremor (lt.and rt.)   Normal in brain CT                                              L-DOPA 300 mg/day (discontinued)                  None                                          Independent on activities of daily living   56                                                        4                                                     Insomnia
  84             M     Hospitalized               IV                   Maprotiline 10 mg/day   Psychiatry                                              Depression                       Limb tremor                Bilateral temporal cortical atrophy                             L-DOPA 100 mg/day                                 Senile dementia                               Able to walk at home                        Unknown                                                   1                                                     Wandering due to dementia
  80             F     Hospitalized               V                    Sulpiride 300 mg/day    Psychiatry                                              Depression                       None                       Lacunes in bilateral white matter                               L-DOPA 100 mg/day                                 None                                          Wheel chair-bound at nursing                Unknown                                                   Unknown                                               None
  81             F     Hospitalized               IV                   Sulpiride 100 mg/day    General practitioner                                    Unknown                          Limb tremor                Lacunes in bilateral white matter and basal ganglia             None                                              None                                          Independent on activities of daily living   Unknown                                                   8                                                     None
  78             F     Hospitalized               V                    Sulpiride 150 mg/day    General hospital surgery                                Unknown                          None                       Widespread white matter                                         None                                              Vascular dementia                             Wheel chair-bound at nursing                Unknown                                                   Unknown                                               None
  84             M     Hospitalized               IV                   Sulpiride 200 mg/day    Psychiatry                                              Depression                       None                       Periventricular lucency in brain CT                             None                                              Depression                                    Able to walk at nursing home                Unknown                                                   Unknown                                               Insomnia, dementia
  87             M     Hospitalized               V                    Sulpiride 100 mg/day    Psychiatry                                              Unknown                          Limb tremor                Widespread white matter hyperintensities                        Amantadine 400 mg/day, bromocriptine 7.5 mg/day   Vascular dementia                             Died from malignant syndrome                8                                                         Unknown                                               Died
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